Tevogen Bio Holdings Inc. financial data

Symbol
TVGN, TVGNW on Nasdaq
Location
15 Independence Boulevard, Suite 410, Warren, NJ
State of incorporation
DE
Fiscal year end
December 31
Former names
Semper Paratus Acquisition Corp (to 2/15/2024)
Latest financial report
10-Q - Q3 2024 - Nov 19, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 8.75 % -74%
Debt-to-equity -114 % -399%
Return On Equity -184 % -334%
Return On Assets 1.28K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 175M shares
Common Stock, Shares, Outstanding 171M shares
Entity Public Float 25.5M USD -92.6%
Common Stock, Value, Issued 17.1K USD
Weighted Average Number of Shares Outstanding, Basic 170M shares +41.8%
Weighted Average Number of Shares Outstanding, Diluted 170M shares +41.8%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 3.26M USD +192%
General and Administrative Expense 14.9M USD +321%
Costs and Expenses 29.5M USD +884%
Operating Income (Loss) -6.09M USD -162%
Nonoperating Income (Expense) 2.21M USD -58.8%
Net Income (Loss) Attributable to Parent 52.5M USD -50.7%
Earnings Per Share, Basic -0.03 USD/shares 0%
Earnings Per Share, Diluted -0.03 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 25M USD +17377%
Assets, Current 3.53M USD +783%
Property, Plant and Equipment, Net 337K USD
Operating Lease, Right-of-Use Asset 291K USD
Other Assets, Noncurrent 133K USD
Assets 4.29M USD -83.8%
Accounts Payable, Current 5.84M USD
Accrued Liabilities, Current 1.41M USD
Liabilities, Current 10.4M USD +470%
Operating Lease, Liability, Noncurrent 42.6K USD
Liabilities 10.5M USD -36.7%
Retained Earnings (Accumulated Deficit) -104M USD -543%
Stockholders' Equity Attributable to Parent -6.19M USD +93.2%
Liabilities and Equity 4.29M USD -83.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.16M USD +0.61%
Net Cash Provided by (Used in) Financing Activities 2.43M USD -2.83%
Net Cash Provided by (Used in) Investing Activities -133K USD
Common Stock, Shares Authorized 800M shares
Common Stock, Shares, Issued 171M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.33M USD -10.6%
Depreciation 40.6K USD +2.06%
Payments to Acquire Property, Plant, and Equipment 133K USD
Operating Lease, Liability, Current 259K USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares +1900%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 90.9M USD
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 3.33M USD
Interest Expense 12.5K USD -95.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%